MAPT and early-onset autosomal dominant Alzheimer disease: Alzheimer’s disease (AD), characterized by the pathological accumulation of amyloid-β (Aβ) and hyperphosphorylated Tau proteins, remains a major global health challenge with limited therapeutic options.